Diagnosing the difference between pancreatic cancer and chronic pancreatitis is difficult because both conditions produce similar symptoms such as inflammation. But Mayo Clinic scientists say they've discovered a biomarker that will help make the job much easier down the line.
New genetic and epigenetic alterations in the genome discovered by scientists at The Cancer Genome Atlas Research Network offer promising disease markers for acute myeloid leukemia--a finding that may have narrowed the search for drug targets.
A group of investigators say they put one theory related to prostate cancer to the test, and came up with some data indicating it's a dead end for developers as well as doctors looking for the right therapeutic strategy for patients.
A team of investigators believe they've come up with a convincing profile for a particular type of tumor cell that could be used as a biomarker for diseases progression as well as a target for drug developers looking to identify a next-gen therapeutic.
Scientists at the University of Illinois have used the Cancer Genome Atlas to pinpoint dozens of biomarkers that can gauge a patient's survival prospects with ovarian cancer and also predict when the cancer might return.
Doctors at the University of Mississippi Medical Center accurately gauged whether antiangiogenic treatments are working in melanoma patients by using CT imaging combined with measurements of a key biomarker.
For women with a very aggressive form of breast cancer, a newly discovered biomarker could indicate how much they might benefit from a recently approved drug.
Call it biomarker repurposing. Researchers have identified a compound produced by the body that can flag smokers at increased risk for lung cancer--a substance long used to gauge liver function.
Researchers had placed high hopes behind using the ERCC1 protein as a biomarker to gauge the response non-small cell lung cancer-patients might display to a certain kind of chemotherapy. But a group of French researchers have cast doubts on its viability.
Danish researchers believe they've uncovered 72 inherited genetic defects that predispose men to prostate cancer--a finding that could help doctors identify men at high risk, diagnose prostate cancer earlier and treat patients more effectively.